Balanced news tone
News Sentiment
4978 sentiment intelligence
ReproCELL Incorporated news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
57
Balanced news tone
7 relevant articles
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-0.8% over one week, +1.6% over four weeks, trend inactive, and below fair value.
Price to sales forward of ReproCELL Inc. – TSE:4978
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
78/100 classification
One-week reaction
-0.8%
Price digesting
Trend fit
Trend inactive
1.6% over four weeks
Fair value
-21.9%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
5
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingView
Direct company coverage
Price to sales forward of ReproCELL Inc. – TSE:4978
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 05:31
- Source
- TradingView
PR Newswire
Direct company coverage
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 24 Jun 2026 07:00
- Source
- PR Newswire
Moomoo
Direct company coverage
Top news this morning! ★ Keep an eye on ReproCELL, Polaris Holdings, and JX Metals!
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Moomoo
BioInformant
Direct company coverage
REPROCELL’s StemRNA™ iPSC Seed Stock Clones for Seamless Translational Research
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Aug 2025 07:00
- Source
- BioInformant
Business Upturn
Direct company coverage
Stock market: Chuoh Pack surges 97.66%, Reprocell jumps 32.05% among top Nikkei gainers
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Feb 2025 08:00
- Source
- Business Upturn
Business Upturn
Direct company coverage
Stock market: Reprocell soars 47.17% as top gainer, NCXX Group and Yamagata Bank follow with strong gains
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 04 Feb 2025 08:00
- Source
- Business Upturn
BioInformant
Direct company coverage
Steminent Announces Japan partner ReproCELL has PMDA Approval of CTN for Phase II Trial of Stemchymal® SCA in the Treatment of Spinocerebellar Ataxia in Japan
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 07 Aug 2018 07:00
- Source
- BioInformant